In partnership with

Scientific Advisory Panel

Home > About Us > Scientific Advisory Panel

Jo Bury PhD

Chief Executive Officer, VIB, Ghent Belgium

Dr. Rainer Fuchs

Life Science and IT Consultant,
Angel investor with Sky Ventures, USA

Dr. Achim Plum

Chief Executive Officer of InfanDx, Cologne, Germany

Prof. Dr. Karl Riabowol

Professor at University of Calgary, Canada

Janna Saarela MD, PhD

Director at Centre for Molecular Medicine Norway

Dr. Yannick Schwab

Group Leader, EMBL , Heidelberg, Germany

Dr. Yannick Schwab

Group Leader, EMBL , Heidelberg, Germany

Prof. Dr. Luis Serrano

Director, Centre of Genomic Regulation, Barcelona, Spain

Dr. Judith Zaugg

Group Leader, EMBL , Heidelberg, Germany

Dr. Judith Zaugg

Group Leader, EMBL, Heidelberg, Germany

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 739593. HCEMM supported by EU Programme: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions. Project starting date was 1 April 2017.

Consortium

About HCEMM

Hungarian Centre of Excellence for Molecular Medicine is a strong catalyst of reformative changes in biomedical science and in institutional research management.

National VAT number: 26307383-2-06
EU VAT number: HU26307383

Internal Policies

Contact Info

© 2021 Hungarian Centre of Excellence for Molecular Medicine, all rights reserved. Hungarian Centre of Excellence for Molecular Medicine® and HCEMM® are registered trademarks of the the HCEMM Nonprofit Ltd.